Berkman Charles S Insider Trading Activity

Average Profitability
29.71%
Insider Buys Quantity
4
Insider Buys Sum
$41,343.00
Insider Sells Quantity
20
Insider Sells Sum
$11.96M

Insider Activity of Berkman Charles S

According to the SEC Form 4 filings, Berkman Charles S, being in a position of

  1. Chief Legal Officer at OmniAb, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 31864 shares for $54,854,
    over all time since 2024-04-08, has bought 0 shares, and sold 95005 shares for $278,486.

Biography of Berkman Charles S

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $54,8544100

Comparison of Insiders on Amount of Buys and Sells

2026-04-07SaleOmniAb, Inc.
OABI
Chief Legal Officer
7,157
0.0062%
$1.49$10,664+67.88%
2026-02-18SaleOmniAb, Inc.
OABI
Chief Legal Officer
9,673
0.009%
$1.71$16,541+34.5%
2026-02-17SaleOmniAb, Inc.
OABI
Chief Legal Officer
6,990
0.0065%
$1.70$11,883+34.21%
2025-12-08SaleOmniAb, Inc.
OABI
Chief Legal Officer
8,044
0.0074%
$1.96$15,766+3.02%
2025-04-07SaleOmniAb, Inc.
OABI
Chief Legal Officer
7,206
0.0057%
$2.00$14,412-16.75%
2025-02-19SaleOmniAb, Inc.
OABI
Chief Legal Officer
7,255
0.006%
$3.67$26,626-50.95%
2025-02-18SaleOmniAb, Inc.
OABI
Chief Legal Officer
8,215
0.0066%
$3.68$30,231-50.82%
2025-01-21SaleOmniAb, Inc.
OABI
Chief Legal Officer
25,489
0.0211%
$3.24$82,584-42.55%
2024-12-09SaleOmniAb, Inc.
OABI
Chief Legal Officer
8,022
0.0067%
$4.13$33,131-54.19%
2024-04-08SaleOmniAb, Inc.
OABI
Chief Legal Officer
6,954
0.0059%
$5.27$36,648-23.54%
2018-09-17SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
2,813
0.0053%
$100.38$282,369-52.38%
2018-09-04SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
19,417
0.0906%
$254.99$4.95M-52.36%
2017-08-09SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
18,625
0.0884%
$126.96$2.36M+21.97%
2016-08-05SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
4,295
0.0205%
$123.16$528,972-13.34%
2015-07-10SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
14,067
0.0703%
$99.14$1.39M+2.57%
2015-03-16SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
6,000
0.0305%
$74.51$447,060+26.72%
2014-12-31PurchaseLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
126
0.0005%
$45.23$5,699+68.79%
2014-06-30PurchaseLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
329
0.0011%
$43.79$14,408-11.18%
2014-05-27SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
4,667
0.0224%
$66.89$312,176-17.55%
2014-02-12SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
2,122
0.003%
$21.70$46,048-25.47%
Total: 28
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.